Книжная полка Сохранить
Размер шрифта:
А
А
А
|  Шрифт:
Arial
Times
|  Интервал:
Стандартный
Средний
Большой
|  Цвет сайта:
Ц
Ц
Ц
Ц
Ц

Rh Isoimmunization in Pregnancy, Hemolytic Disease of the Fetus and Newborn: Management, Diagnosis, Treatment

Покупка
Новинка
Артикул: 891924.01.99
Доступ онлайн
350 ₽
В корзину
This textbook for the discipline "Obstetrics and Gynecology” complies with the requirements of the Federal State Educational Standard of Higher Education (2020) for specialty 31.05.01 General Medicine. The present textbook covers issues of Rh isoimmunization in pregnancy, as well as hemolytic disease of the fetus and newborn. Includes figures, tables, test questions. It is intended for students in their 4th—6th years of study in specialty 31.05.01 General Medicine.
Rh Isoimmunization in Pregnancy, Hemolytic Disease of the Fetus and Newborn: Management, Diagnosis, Treatment : training manual / compilers A. I. Pashov, N. N. Nikishov, A. S. Turdieva, A.Sh. Turdiev. — Kaliningrad : Immanuel Kant Baltic Federal University Press, 2026. - 56 с. - ISBN 978-5-9971-1034-5. - Текст : электронный. - URL: https://znanium.ru/catalog/product/2276817 (дата обращения: 18.11.2026). – Режим доступа: по подписке.
Фрагмент текстового слоя документа размещен для индексирующих роботов
IMMANUEL KANT BALTIC FEDERAL UNIVERSITY 
 
 
 
 
 
 
 
RH ALLOIMMUNIZATION IN PREGNANCY:  
COMPREHENSIVE STRATEGIES FOR THE DIAGNOSIS  
AND MANAGEMENT OF HEMOLYTIC DISEASE  
OF THE FETUS AND NEWBORN 
 
Training manual 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Immanuel Kant Baltic Federal University Press 
2026 
 
 


UDK 616.15-0.53+618.3(075.8) 
BBK 57.162.1 
         R51 
 
Reviewers 
 
Dr M. I. Bazina, Associate Professor,  
V. F. Voyno-Yasenetsky Krasnoyarsk State Medical University; 
Dr NT. M. Sokolova, Professor, Novosibirsk State Medical University 
 
 
 
 
 
 
 
 
R51    Rh Isoimmunization in Pregnancy, Hemolytic Disease of 
the Fetus and Newborn: Management, Diagnosis, Treatment : training manual / compilers A. I. Pashov, N. N. Nikishov, A. S. Turdieva, A.Sh. Turdiev. — Kaliningrad : Immanuel Kant Baltic Federal University Press, 2026. — 56 p. 
ISBN 978-5-9971-1034-5 
 
This textbook for the discipline “Obstetrics and Gynecology” complies with the requirements of the Federal State Educational Standard of 
Higher Education (2020) for specialty 31.05.01 General Medicine. The 
present textbook covers issues of Rh isoimmunization in pregnancy, as 
well as hemolytic disease of the fetus and newborn. Includes figures, tables, test questions. 
It is intended for students in their 4th—6th years of study in specialty 
31.05.01 General Medicine. 
 
UDK 616.15-0.53+618.3(075.8) 
BBK 57.162.1 
 
© Pashov A. I., Nikishov N. N., Turdieva A. S.,  
Turdiev A. Sh., compilers, 2026 
ISBN 978-5-9971-1034-5               © Design, IKBFU, 2026 
 


 
ОГЛАВЛЕНИЕ 
 
Preface ...................................................................................................
Part I. Rhesus (Rh) isoimmunization in pregnancy. hemolytic 
disease of the fetus ................................................................................
6
Definition ...............................................................................................
7
Etiology and Pathogenesis .....................................................................
7
Epidemiology .........................................................................................
7
Classification.......................................................................................... 11
Diagnosis of Hemolytic Disease of the Fetus ........................................ 12
Clinical Presentation .............................................................................. 13
Physical Examination ............................................................................. 13
Instrumental Diagnostics ........................................................................ 15
Treatment of Hemolytic Disease of the Fetus ........................................ 16
Conservative Treatment .................................................................... 16
Intrauterine Intravascular Transfusion of Packed Red Blood Cells 
to the Fetus ............................................................................................. 17
Management of Pregnancies with HDF Requiring Intrauterine Transfusion ..................................................................................................... 18
Management of Labor in Rh-Isoimmunized Pregnancies ...................... 19
Prevention of Rh Isoimmunization ........................................................ 20
Non-Specific Prophylaxis ...................................................................... 21
Specific Antenatal Prophylaxis of Rh Isoimmunization ........................ 21
Self-assessment test questions ............................................................... 24
Part II. Hemolytic disease of the newborn. Diagnosis. Treatment ... 28
Definition and Key Links in the Pathogenesis of HDN ......................... 28
Classification of Hemolytic Disease of the Newborn ............................ 29
Complications of HDFN ........................................................................ 33
Diagnosis ............................................................................................... 34
Treatment ............................................................................................... 37


Operative Treatment: Exchange Blood Transfusion (EBT) ................... 42
Prognosis ................................................................................................ 47
Self-assessment test questions ............................................................... 47
Appendices ............................................................................................ 51
List of Abbreviations and Symbols ..................................................... 52
References ............................................................................................. 54
 
 
 


 
 
 
PREFACE 
 
Despite significant advances in perinatal medicine, the problem 
of hemolytic disease of the fetus and newborn in the context of 
immunoconflict pregnancy cannot be considered completely resolved in our country [2; 3; 14; 15]. Hemolytic disease of the fetus 
is diagnosed in approximately 0.6 % of newborns in the Russian 
Federation, and the incidence of Rh isoimmunization has not yet 
shown a significant downward trend in recent years [14; 15]. 
Perinatal mortality rates due to hemolytic disease of the fetus 
remain high, ranging from 15 to 16 ‰ [14; 15; 16]. A significant reduction in perinatal morbidity and mortality from hemolytic disease 
of the fetus is impossible without organizing measures for the timely 
and universal prevention of Rh isoimmunization during pregnancy 
and in the early postpartum period at the population level. 
Furthermore, advances in molecular genetic technologies have 
now made it possible to non-invasively determine the fetal Rh genotype in an Rh-negative mother as early as the end of the first trimester of pregnancy through prenatal testing of cell-free fetal DNA 
in maternal blood samples, with a sensitivity and specificity of 
98—100 %. The possibility of non-invasive determination of the 
fetal Rh genotype in Rh-negative pregnant women allows for a reduction in pregnancy management costs, avoidance of multiple 
screening tests for Rh antibodies, and ensures the preventive use of 
anti-Rh immunoprophylaxis only in cases of a Rh-positive fetal 
genotype. If determining the fetal Rh genotype is not possible, the 
pregnancy in an Rh-negative woman should be managed as if carrying a Rh-positive fetus [14; 15]. 
In Rh-isoimmunized women, determining the fetal Rh-D gene 
avoids unnecessary invasive diagnostic and therapeutic procedures 
if the fetal blood type is Rh-negative. In cases of a Rh-positive fe
 
tus, the method allows for early assessment of the risk of developing hemolytic disease of the fetus and timely initiation of diagnostic measures. 
The use of preimplantation genetic testing in IVF programs 
when the father has a heterozygous genotype for the Rh factor 
(RhD+/RhD–) enables families who have experienced fetal or newborn loss due to hemolytic disease to perform selective transfer of 
embryos with a homozygous Rh-negative genotype into the uterine 
cavity, thereby preventing the potential development of hemolytic 
disease in these fetuses. 
It is important to note that for the healthcare system, the costs 
associated with implementing the prevention of Rh isoimmunization are significantly lower compared to the costs of treating hemolytic disease of the fetus and newborn [14; 15].  
 
 
 


Доступ онлайн
350 ₽
В корзину